Edition:
United Kingdom

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

4.03USD
15 Aug 2018
Change (% chg)

-- (--)
Prev Close
$4.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,040
52-wk High
$5.93
52-wk Low
$4.01

Chart for

About

Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses,... (more)

Overall

Beta: 1.56
Market Cap(Mil.): $244.17
Shares Outstanding(Mil.): 47.05
Dividend: --
Yield (%): --

Financials

  CMRX.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.43 -- --
ROI: -24.14 1.78 14.61
ROE: -24.17 3.28 16.33

BRIEF-Chimerix Announces Martha J. Demski As Board Chair

* CHIMERIX ANNOUNCES MARTHA J. DEMSKI AS BOARD CHAIR; APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS

29 Mar 2018

BRIEF-Chimerix Announces Q4 Loss Per Share $0.41

* CHIMERIX ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

01 Mar 2018

Earnings vs. Estimates